These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1576 related items for PubMed ID: 9466278

  • 21. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL, Avalos BR, Belt P, Taylor CA, Ezzone SA, Scholl MD, Fisher J, Young D, Copelan EA.
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [Abstract] [Full Text] [Related]

  • 22. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

  • 23. [Allogeneic bone marrow transplantation in chronic myeloid leukemia. The clinical results and risk factors in 70 patients].
    Tomás JF, Peñarrubia MJ, García JA, Figuera A, Gómez-García de Soria V, Steegmann JL, Arranz R, Cámara R, Gabriel R, Vázquez L.
    Med Clin (Barc); 1995 Nov 11; 105(16):605-11. PubMed ID: 8523939
    [Abstract] [Full Text] [Related]

  • 24. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
    Bishop MR, Henslee-Downey PJ, Anderson JR, Romond EH, Marciniak E, Yankey R, Reeves M, Thompson JS.
    Bone Marrow Transplant; 1996 Oct 11; 18(4):747-53. PubMed ID: 8899190
    [Abstract] [Full Text] [Related]

  • 25. Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival.
    Ringdén O, Aschan J, Boström L, Dahllöf G, Tollemar J, Paulin T, Gahrton G, Groth CG, Klaesson S, Lindquist R.
    Clin Transpl; 1990 Oct 11; ():175-87. PubMed ID: 2103143
    [Abstract] [Full Text] [Related]

  • 26. Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors.
    Mackinnon S, Hows JM, Goldman JM, Arthur CK, Hughes T, Apperley JF, Jones L, Batchelor JR, Brookes P, Catovsky D.
    Exp Hematol; 1990 Jun 11; 18(5):421-5. PubMed ID: 2338131
    [Abstract] [Full Text] [Related]

  • 27. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ, Miller W, Kandaswamy C, DeFor TE, MacMillan ML, Van Burik JA, Weisdorf DJ.
    Bone Marrow Transplant; 2002 Dec 11; 30(12):945-51. PubMed ID: 12476289
    [Abstract] [Full Text] [Related]

  • 28. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G, Foncuberta MC, Aversa L, Drelichman G, Freigeiro D, Burgos R, Irrazabal C, Gonzalez G, Dictar M, Niborski R, Kohan A, Sanchez Avalos JC.
    Medicina (B Aires); 2000 Dec 11; 60(2):179-87. PubMed ID: 10962806
    [Abstract] [Full Text] [Related]

  • 29. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
    Sanz GF, Saavedra S, Jiménez C, Senent L, Cervera J, Planelles D, Bolufer P, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, de la Rubia J, Barragán E, Solves P, Soler MA, Sanz MA.
    Bone Marrow Transplant; 2001 Apr 11; 27(7):693-701. PubMed ID: 11360108
    [Abstract] [Full Text] [Related]

  • 30. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Apr 11; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 31. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Apr 11; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 32. [Bone marrow transplantation from unrelated donors in chronic myeloid leukemia: the results in 15 patients].
    Sierra J, Carreras E, Rovira M, Batlle M, Urbano-Ispizua A, Marín P, Besson I, Merino A, Algara M, Cervantes F.
    Med Clin (Barc); 1995 May 13; 104(18):689-94. PubMed ID: 7769878
    [Abstract] [Full Text] [Related]

  • 33. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F, Szydlo RM, Hermans J, Devergie A, Frassoni F, Arcese W, de Witte T, Kolb HJ, Niederwiser D, Jacobsen N, Gahrton G, Bandini G, Carreras E, Bacigalupo A, Michallet M, Ruutu T, Reiffers J, Goldman JM, Apperley J, Gratwohl A.
    Bone Marrow Transplant; 1997 Oct 13; 20(7):553-60. PubMed ID: 9337056
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
    Carlens S, Ringdén O, Remberger M, Lönnqvist B, Hägglund H, Klaesson S, Mattsson J, Svahn BM, Winiarski J, Ljungman P, Aschan J.
    Bone Marrow Transplant; 1998 Oct 13; 22(8):755-61. PubMed ID: 9827972
    [Abstract] [Full Text] [Related]

  • 35. Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation.
    Bacigalupo A, Soracco M, Vassallo F, Abate M, Van Lint MT, Gualandi F, Lamparelli T, Occhini D, Mordini N, Bregante S, Figari O, Benvenuto F, Sessarego M, Fugazza G, Carlier P, Valbonesi M.
    Bone Marrow Transplant; 1997 May 13; 19(9):927-32. PubMed ID: 9156268
    [Abstract] [Full Text] [Related]

  • 36. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 13; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 37. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
    Dini G, Boni L, Abla O, Uderzo C, Polchi P, Locatelli F, Di Bartolomeo P, Arcese W, Iori AP, Rossetti F.
    Bone Marrow Transplant; 1994 Jun 13; 13(6):771-6. PubMed ID: 7920313
    [Abstract] [Full Text] [Related]

  • 38. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT, Reiter E, Schulenburg A, Keil F, Lechner K, Fischer G, Rosenmayr A, Leitner G, Kalhs P.
    Bone Marrow Transplant; 1998 Dec 13; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [Abstract] [Full Text] [Related]

  • 39. Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia.
    Reiter E, Greinix HT, Brugger S, Keil F, Rabitsch W, Mannhalter C, Schwarzinger I, Höcker P, Fischer G, Dieckmann K, Hinterberger W, Linkesch W, Schneider B, Lechner K, Kalhs P.
    Bone Marrow Transplant; 1998 Dec 13; 22 Suppl 4():S86-8. PubMed ID: 9916646
    [Abstract] [Full Text] [Related]

  • 40. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun 13; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 79.